World-renowned experts in the field of adult stem cell research will exchange ideas and best practices during the 2007 Adult Mesenchymal Stem Cells (MSC) in Regenerative Medicine conference August 27-29 in downtown Cleveland. The National Center for Regenerative Medicine for Stem Cell and Regenerative Medicine (NCRM), in addition to founding partner Case Western Reserve University, is responsible for the organization and planning of this meeting.
"Educating researchers in methods and models in mesenchymal stem cell technology has been a priority of our key investigators such as Dr. Arnold Caplan and Dr. Stanton Gerson, who are part of the MSC 2007 organizing committee. Education and information exchange have been compelling forces for hosting this conference. We also want to establish Cleveland in the biotechnology world as the place to be for adult stem cell research," said Michael Gilkey, marketing and operations manager for the NCRM.
Currently, the center has over 27 ongoing clinical trials using adult stem cells, and provides a comprehensive approach to developing therapies for patients suffering from chronic and debilitating diseases.
According to Gilkey, the conference will feature international and national researchers representing 22 countries across the world, including Australia, Brazil, Canada, Korea and Japan, along with major biotech states such as California, Florida, Massachusetts, and Texas. According to its Web site, the conference will focus on the technological and clinical advances of using mesenchymal stem cells derived from a variety of tissues (such as bone marrow, fat, cord blood, cord matrix, and amniotic fluid).
The target audience includes new and experienced investigators in the MSC field, students, physicians and commercial entities interested in therapeutic opportunities with these cell types. In addition, junior investigators and students will be given a venue to present their research in poster session and invited presentations. The overall goal is to provide a forum for exchange and discussion for this area of regenerative medicine.
"We want to bring people in to Ohio and provide a venue to create new collaborations across national and international boundaries," Gilkey added when questioned as to why the center took on the responsibility for creating this international conference. The meeting also fits with one of the NCRM's immediate goals to teach post-doctorate students across the globe about effective research techniques in regenerative medicine.
The National Center for Regenerative Medicine in Cleveland brings together researchers and physicians from Case Western Reserve University, the Cleveland Clinic and University Hospitals Case Medical Center. The NCRM provides a comprehensive approach, including basic and clinical research as well as biomedical and tissue engineering, to develop new adult (non-embryonic) stem cell therapies for patients suffering from chronic and debilitating diseases including heart disease, cancer, genetic disorders and neurodegenerative diseases and injuries such as multiple sclerosis and spinal cord injury.
Those interested in attending the conference may register online.For more information, contact Kimyette Finley at 216.368.0521.
Case Western Reserve University is committed to the free exchange of ideas, reasoned debate and intellectual dialogue. Speakers and scholars with a diversity of opinions and perspectives are invited to the campus to provide the community with important points of view, some of which may be deemed controversial. The views and opinions of those invited to speak on the campus do not necessarily reflect the views of the university administration or any other segment of the university community.